<div><a href="https://www.youtube.com/shorts/Um2nOe5-UwM" target="_blank" rel="noreferrer noopener">Access to Cancer Medicines for all</a>
</div>
<div>What if your survival depended on a medicine you couldn’t afford or even access?
</div>
<div><br />
</div>
<div>This is the devastating reality for millions of people with cancer in low- and middle-income countries (LMICs), where essential cancer drugs remain <strong>out of reach</strong>. Diagnoses often come too late. Pain relief is scarce. And treatment? Sometimes nonexistent.
</div>
<div><br />
</div>
<div>At <a href="https://inspire2live.org" target="_blank" rel="noreferrer noopener">Inspire2Live</a> , we believe that <em>where you live should not determine whether you live</em>. That’s why we’ve launched a global initiative to make lifesaving cancer medicines accessible, <strong>regardless of income, status, or geography.</strong>
</div>
<div>Barbara Moss, a Stage IV colon cancer survivor and Inspire2Live advocate from the UK, remembers what it was like to be denied access to life-saving treatment simply because it was “too expensive”:
</div>
<div><br />
</div>
<div>“If my family hadn’t paid for the biological drug, I would not be alive today. The drug shrank my tumours and gave me the chance to have surgery. Eighteen years later, I’m still here.”
</div>
<div><br />
</div>
<div>And now, she’s fighting for others to have that same chance:
</div>
<div><br />
</div>
<div><strong>“We believe that it is inhumane to allow people to suffer and die when there is a known way of preventing this.”</strong>
</div>
<div><br />
</div>
<div><strong> The Crisis</strong>
</div>
<div><br />
</div>
<div>•	Only <strong>20% of the world’s medicine</strong> reaches <strong>80% of its population.</strong>
</div>
<div><br />
</div>
<div>•	Of the 83 essential cancer drugs listed by WHO, many are simply <strong>unavailable</strong> in LMICs.
</div>
<div><br />
</div>
<div>•	These are not rare, experimental drugs. They’re proven treatments that <strong>could be saving lives today.</strong>
</div>
<div><br />
</div>
<div>This isn’t just a global health issue. It’s a matter of <strong>justice</strong>.
</div>
<div><br />
</div>
<div><strong>The Solution</strong>
</div>
<div><br />
</div>
<div>Just like the successful model for HIV treatment, we can:
</div>
<div><br />
</div>
<div>•	Make medicines under <strong>patent</strong> available as <strong>generics</strong> in LMICs
</div>
<div><br />
</div>
<div>•	<strong>Lower production costs</strong> by up to 90% after use in high-income countries.
</div>
<div><br />
</div>
<div>•	Enable <strong>local manufacturing and registration</strong> <strong>without harming pharma profits.</strong>
</div>
<div><br />
</div>
<div>The science exists. The system works. We just need the will and the funding to make it happen.
</div>
<div><br />
</div>
<div><strong>What Your Donation Will Do</strong>
</div>
<div><br />
</div>
<div>Your support will help us:
</div>
<div><br />
</div>
<div>•	Register essential cancer drugs in LMICs.
</div>
<div><br />
</div>
<div>•	Support local, safe production of generic medicines.
</div>
<div><br />
</div>
<div>•	Launch on-the-ground advocacy and partnerships.
</div>
<div><br />
</div>
<div>•	Ensure <strong>equity in cancer care</strong>, globally.
</div>
<div><br />
</div>
<div>We are backed by <strong>leading scientists, global health leaders, and patient advocates</strong> around the world. But we need <strong>you</strong> to take this movement forward.
</div>
<div><br />
</div>
<div>Please donate today.
</div>
<div>Help us bring cancer care where it’s needed most.
</div>
<div>Because <strong>medicine should heal everyone. Not just the lucky few</strong>.
</div>

Anonymous

Célimène Galiger

Nicole Stolk

Dini Hilbron

Bas Westerweel

Erik Roos

Peter Hoogweg

Annette Cornelisse

Guido Schouw

Jean-Philippe de Lannoy

Toine Pieters

Parag Mankeekar

Access to Cancer Treatment for all

Access to Cancer Treatment for all

Still €21,891 to go. Help us build momentum.